SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $7,000 | -99.8% | 63,491 | -96.6% | 0.00% | -100.0% |
| Q3 2018 | $3,186,000 | +2.9% | 1,873,597 | +5.2% | 0.00% | 0.0% |
| Q2 2018 | $3,097,000 | -7.3% | 1,780,277 | -2.5% | 0.00% | 0.0% |
| Q1 2018 | $3,342,000 | -45.8% | 1,826,266 | -33.9% | 0.00% | 0.0% |
| Q4 2017 | $6,163,000 | -30.1% | 2,763,538 | -18.8% | 0.00% | -50.0% |
| Q3 2017 | $8,820,000 | -0.3% | 3,405,377 | +71.3% | 0.00% | 0.0% |
| Q2 2017 | $8,848,000 | +53.7% | 1,988,200 | +60.9% | 0.00% | +100.0% |
| Q1 2017 | $5,758,000 | -26.0% | 1,235,725 | -3.3% | 0.00% | -50.0% |
| Q4 2016 | $7,782,000 | +8.6% | 1,277,775 | -1.8% | 0.00% | 0.0% |
| Q3 2016 | $7,168,000 | +52.3% | 1,300,944 | +5.1% | 0.00% | +100.0% |
| Q2 2016 | $4,705,000 | +30.7% | 1,238,196 | -5.1% | 0.00% | 0.0% |
| Q1 2016 | $3,600,000 | -37.9% | 1,304,086 | +27.6% | 0.00% | 0.0% |
| Q4 2015 | $5,795,000 | -5.4% | 1,022,095 | -11.5% | 0.00% | -50.0% |
| Q3 2015 | $6,124,000 | +127.2% | 1,155,320 | +255.8% | 0.00% | +100.0% |
| Q2 2015 | $2,695,000 | +839.0% | 324,695 | +214.0% | 0.00% | – |
| Q3 2014 | $287,000 | -34.2% | 103,399 | -3.5% | 0.00% | – |
| Q2 2014 | $436,000 | +71.0% | 107,178 | +123.2% | 0.00% | – |
| Q1 2014 | $255,000 | +160.2% | 48,026 | +122.1% | 0.00% | – |
| Q3 2013 | $98,000 | -39.5% | 21,623 | -42.3% | 0.00% | – |
| Q2 2013 | $162,000 | – | 37,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|